The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients
NCT00001070 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2023-04-14
Summary
This is a study to evaluate the tolerance and antiviral effect of oral vitamin C in HIV-infected.
Conditions
- HIV Infections
Interventions
- DRUG
-
Oral Vitamin C
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus
NCT00361101 ·Status: COMPLETED ·Phase: PHASE1
-
Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients
NCT05224492 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.
NCT02206711 ·Status: COMPLETED ·Phase: PHASE1
-
Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon
NCT00658346 ·Status: COMPLETED
-
A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects
NCT00397566 ·Status: WITHDRAWN ·Phase: PHASE2
-
Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects
NCT00000740 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides
NCT00389311 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)
NCT06045507 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial (MTN-003)
NCT02358616 ·Status: COMPLETED
-
Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol
NCT03517358 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Lobucavir in Patients With AIDS
NCT00002352 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
NCT00000823 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body
NCT01045317 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
NCT01064752 ·Status: COMPLETED
-
A Study of DPC 817 in HIV-Infected Males
NCT00040274 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
NCT00000657 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex
NCT00000710 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex
NCT00001011 ·Status: COMPLETED ·Phase: PHASE3
-
MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy
NCT03570918 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
NCT00002097 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
NCT03407105 ·Status: COMPLETED ·Phase: PHASE1
-
A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides
NCT00002114 ·Status: COMPLETED ·Phase: PHASE2
-
Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
NCT00000643 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS
NCT00001024 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Safety and Pharmacokinetics of PC-1005 Administered Rectally to HIV-1 Seronegative Adults
NCT03408899 ·Status: COMPLETED ·Phase: PHASE1